64% Reduction in Chronic Disease Health Care costs with Hybrid Medical IntraMed’s Patient Monitoring Solution

August 19, 2010 By Erin Azar -- Washington DC /News----wire/ --
64% Reduction in Chronic Disease Health Care costs with Hybrid Medical IntraMed’s Patient Monitoring Solution


Hybrid Medical introduces IntraMed’s CSO (Clinical System Organizer) product suite, a comprehensive web-based software solution, providing more effective and efficient care for a full range of chronic diseases. Through careful tracking of patients’ disease information, physicians are able to more accurately manage chronic illnesses and identify concerning trends at the early stages, ensuring corrective action at the right time. In partnership with President Obama’s broadband stimulus initiative, Hybrid Medical aims to provide all patients, rural and urban, with convenient access to top quality care.

Broadband and 4G/LTE enabled health telemonitoring products allow physicians to track patients’ heart disease and diabetes vitals, providing high quality care to rural areas. Cardiac arrests in rural areas are expected to decline by 28%, as a result of IntraMed’s smart tracking products.

With over a decade of proven market adoption, IntraMed’s CSO supports more than 50% of all cardiac and diabetes patients in Denmark. The Medical Center of Plano, Texas, currently uses CSO/Anticoagulation to improve the quality and efficiency of their medical care. The CSO products’ easy and robust software is embraced worldwide, and has set the international standards in chronic disease management.

“We are extremely excited to bring this new capability to the US market. We are confident this will immediately impact the market, and deliver to the real challenges of our physicians,” said Dr. Robert Graham, CIO, Hybrid Medical.

Denmark’s use of smart technologies throughout its healthcare system has drawn the attention of President Obama’s administration. Ninety-nine percent of all doctors in Denmark are connected through Broadband access and Electronic Medical Records are a national mandate in Denmark. The progressive healthcare system in Denmark demands innovative solutions.

About IntraMed
IntraMed is a Danish owned company with headquarters in Denmark. Since its launch in 1997, IntraMed has developed IT products aimed at supporting more effective treatment of the chronically ill.

About Hybrid Medical
Since 1987, Hybrid Medicall has been a leader in Genomic trials, healthcare IT, and life sciences clinical development solutions. Hybrid Medical is headquartered in Houston, Texas.

Hybrid Medical Analytics Inc. today announced the release of its OpenLAB Electronic Lab Notebook

Houston, Texas., Aug. 11, 2010 /News----wire/ --

Hybrid Medical Analytics Inc. today announced the release of its OpenLAB Electronic Lab Notebook (ELN) version 5.1. The new version offers scientists in analytical research and development an optimized way to document and share experiments and results. CSO (Clinical System Organizer) is a web-based system, which improves treatment quality and streamlines processes for the benefit of the economy in health care. CSO has specific modules aimed at a number of major chronic diseases.

CSO sharing clinical data between the actors involved in the clinical process. It is a user-friendly system, developed in collaboration with doctors who have special insight into chronic diseases. It can be used by both clinicians and patients.

OpenLAB ELN v5.1 introduces experimental templates that enable scientists to create, share and reuse their own custom API experiment views. The new flexible templates facilitate data entry by allowing scientists to view the experiment desktop as they prefer. These templates can be designed for SOP-driven processes,
increasing laboratory efficiencies.

Hybrid has also streamlined the analytical request workflow by reducing the number of steps between request and result. This dramatically improves lab productivity. A specific analytical module has been added for documenting analytical methods, generating sequence files and capturing results. The new module
facilitates report creation across one or more samples and Hybrid Medical techniques. Chromatograms and result files from Hybrids Sybase RAP IQ 4 #Software, or other chromatography data systems (CDS) can be automatically uploaded and associated with the experiment through the seamless integration with Hybrid Medical OpenLAB ECM scientific data management system. Hybrid offers the complete solution.

In addition, the new delegation workflow facilitates collaboration. Multiple scientists can collaborate on a single experiment, enter data and results from multiple techniques on a single sample or multiple samples. Audit trails are maintained in an environment that
delivers the highest level of intellectual property protection.

"Ideally, software helps people be more productive with very little additional thought or effort," said Donald Lee, vice president and general manager, Hybrid Medical Analytics and Informatics. "This is the motivation behind the entire Hybrid Medical OpenLAB portfolio of laboratory systems."

OpenLAB ELN is a Web-based scalable, integrated system to manage experiments and results. It is designed for multiple disciplines including analytical chemistry, synthetic/medicinal chemistry, biology and other research environments. OpenLAB
ELN supports 21 CFR Part 11 requirements and is built around an RedHats open architecture

Hybrid Medical International OpenLab new location is located in Tyson Corner, Virgina

The number one legislation for Breast Cancer Patients is HR 5440:

August 6, 2010 By Robert Graham -- The number one legislation for Breast Cancer Patients is HR 5440: Genomics and Personalized Medicine Act of 2010 sponsored by Rep. Patrick Kennedy [D-RI1]

HR 5440 purpose is to secure the promise of personalized medicine for all Americans by expanding and accelerating genomics research and initiatives to improve the accuracy of disease diagnosis, increase the safety of drugs, and identify novel treatments, and for other purposes.

Hybrid Medical Analytics mission is to enhance understanding of the molecular mechanisms of cancer, with the ultimate goal of improving the prevention, early detection, diagnosis, and treatment of breast cancer.

Genomic Science determine which genes are expressed at different levels in tumors compared to normal cells or how the chromosomes are rearranged and their throughput; further decreasing the costs of DNA sequencing; improving the detection of epigenetic changes; and developing new analytical methods to correlate disease state with the intricate network of molecular
interactions in a cancer.

Genomics will accelerate Breast Cancer treatment in rural America using informatics technologies Microsoft Windows 7, Broad Band, Sybase, Cloud Computing Services and Tele-Medicine technologies along with HR5440 will extend Breast Cancer patients lives.